An open-label, pilot study to evaluate the benefits of using lyophilized human milk-derived nutritional product (NeoLact 70 – 1.55 g) as an immune-nutritional supplement in premature infants discharged from NICU. Indian Journal of Child Health, [S. l.], v. 8, n. 12, p. 404–407, 2021. DOI: 10.32677/ijch.v8i12.3213. Disponível em: https://mansapublishers.com/index.php/ijch/article/view/3213.. Acesso em: 22 jul. 2024.